Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area

Journal of Infection and Public Health

Volumn 11, Issue 2, 2018, Pages 171-177

  Cristina, Maria L ^a,b   Alicino, Cristiano ^a   Sartini, Marina ^a,b   Faccio, Valeria ^a   Spagnolo, Anna M ^a   Bono, Valerio D ^c   Cassola, Giovanni ^b   De Mite, Anna M ^d   Crisalli, Maria P ^b   Ottria, Gianluca ^a,b   Schinca, Elisa ^a,b   Pinto, Giuliano L ^b   Bottaro, Luigi C ^d   Viscoli, Claudio ^a,c   Orsi, Andrea ^a,c   Giacobbe, Daniele R ^a,c   Icardi, Giancarlo ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Medical Directorate   (Italy)

Author keywords

Bloodstream infection; BSI; Carbapenem resistant Klebsiella pneumoniae; CRKP; Epidemiology

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; COLISTIN; GENTAMICIN; TIGECYCLINE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOODSTREAM INFECTION; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CLINICAL OUTCOME; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; ITALY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; ANTIBIOTIC RESISTANCE; BACTEREMIA; BLOOD; CITY; CLINICAL TRIAL; CROSS INFECTION; DISEASE MANAGEMENT; DRUG EFFECT; HOSPITAL; KLEBSIELLA INFECTION; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; BACTEREMIA; CARBAPENEMS; CITIES; CROSS INFECTION; DISEASE MANAGEMENT; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INCIDENCE; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 85021354791     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2017.06.003     Document Type: Article

References (36)

1. Munoz-Price, L.S., Poirel, L., Bonomo, R.A., Schwaber, M.J., Daikos, G.L., Cormican, M., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13 (2013), 785–796.
2. Nordmann, P., Dortet, L., Poirel, L., Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 18 (2012), 263–272.
3. Marchain, D., Chopra, T., Pogue, J.M., Perez, F., Hujer, A.M., Rudin, S., et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 55 (2011), 593–599.
4. Alicino, C., Giacobbe, D.R., Orsi, A., Tassinari, F., Trucchi, C., Sarteschi, G., et al. Trends in the incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis, 15, 2015, 415.
5. Giani, T., Arena, F., Vaggelli, G., Conte, V., Chiarelli, A., Henrici De Angelis, L., et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol 53 (2015), 3341–3344.
6. Endimiani, A., Hujer, A.M., Perez, F., Bethel, C.R., Hujer, K.M., Kroeger, J., et al. Characterization of blaKPC-containing Klebsiella Pneumoniae isolates detected in different institutions in the eastern USA. J Antimicrob Chemother 63 (2009), 427–437.
7. Jiang, Y., Wei, Z., Wang, Y., Hua, X., Feng, Y., Yu, Y., Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect 21 (2015), 1001–1007.
8. Giacobbe, D.R., Del Bono, V., Marchese, A., Viscoli, C., Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening?. Clin Microbiol Infect 20 (2014), O1157–O1158.
9. Corcione, S., Rocchetti, A., Argentero, P.A., Raso, R., Zotti, C.M., De Rosa, F.G., et al. A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU. Clin Microbiol Infect 21 (2015), e11–e13.
10. Kontopidou, F., Giamarellou, H., Katerelos, P., Maragos, A., Kioumis, I., Trikka-Graphakos, E., et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 20 (2014), O117–O123.
11. Spagnolo, A.M., Orlando, P., Panatto, D., Perdelli, F., Cristina, M.L., An overview of carbapenem-resistant Klebsiella pneumoniae: epidemiology and control measures. Rev Med Microbiol 25 (2014), 7–14.
12. Del Bono, V., Giacobbe, D.R., Marchese, A., Parisini, A., Fucile, C., Coppo, E., et al. Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox?. Virulence 18 (2016), 1–8.
13. Cristina, M.L., Sartini, M., Ottria, G., Schinca, E., Cenderello, N., Crisalli, M.P., et al. Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital. J Prev Med Hyg 57 (2016), E149–E156.
14. Daikos, G.L., Markogiannakis, A., Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenem?. Clin Microbiol Infect 17 (2011), 1135–1141.
15. Tumbarello, M., Trecarichi, E.M., Tumietto, F., Del Bono, V., De Rosa, F.G., Bassetti, M., et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 58 (2014), 3514–3520.
16. Giacobbe, D.R., Del Bono, V., Trecarichi, E.M., De Rosa, F.G., Giannella, M., Bassetti, M., et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study. Clin Microbiol Infect, 21, 2015 1106.e1-8.
17. Daikos, G.L., Tsaousi, S., Tzouvelekis, L.S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58 (2014), 2322–2328.
18. Tumbarello, M., Trecarichi, E.M., De Rosa, F.G., Giannella, M., Giacobbe, D.R., Bassetti, M., et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentric study. J Antimicrob Chemother 70 (2015), 2133–2143.
19. HELICS Surveillance of Nosocomial Infections in Intensive Care Units protocol, version 6.1, September 2004. Available from: http://ecdc.europa.eu/en/activities/surveillance/HAI/Documents/0409_IPSE_ICU_protocol.pdf (accessed 19.06.16).
20. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
21. Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:8 (2016), 801–810.
22. Salsano, A., Giacobbe, D.R., Sportelli, E., Olivieri, G.M., Brega, C., Di Biase, C., et al. Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery. Interact Cardiovasc Thorac Surg, 2016, ivw228.
23. Viale, P., Tumietto, F., Giannella, M., Bartoletti, M., Tedeschi, S., Ambretti, S., et al. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect 21 (2015), 242–247.
24. Giacobbe, D.R., Del Bono, V., Bruzzi, P., Corcione, S., Giannella, M., Marchese, A., et al. Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study. Eur J Clin Microbiol Infect Dis, 2016, 10.1007/s10096-016-2843-1 (in press).
25. Spyropoulou, A., Papadimitriou-Olivgeris, M., Bartzavali, C., Vamvakopoulou, S., Marangos, M., Spiliopoulou, I., et al. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates. J Med Microbiol 65 (2016), 240–246.
26. Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., Ghitan, M., et al. Rise and fall of KPC-producing Klebsiella pneumoniae in New York City. J Antimicrob Chemother 71 (2016), 2945–2948.
27. Paul, M., Carmeli, Y., Durante-Mangoni, E., Mouton, J.W., Tacconelli, E., Theuretzbacher, U., et al. Combination therapy for carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 69 (2014), 2305–2309.
28. Dickstein, Y., Leibovici, L., Yahav, D., Eliakim-Raz, N., Daikos, G.L., Skiada, A., et al. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol. BMJ Open, 6(April (4)), 2016, e009956.
29. Pea, F., Della Siega, P., Cojutti, P., Sartor, A., Crapis, M., Scarparo, C., et al. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?. Int J Antimicrob Agents 49 (2017), 255–258.
30. Chen, H.C., Lin, W.L., Lin, C.C., Hsieh, W.H., Hsieh, C.H., Wu, M.H., et al. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 68 (2013), 947–953.
31. Retamar, P., Portillo, M.M., Lopez-Prieto, M.D., Rodriguez- Lopez, F., de Cueto, M., Garcia, M.V., et al. Impact of inadequate empirical therapy on the mortality of patients with blood-stream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56 (2012), 472–478.
32. Del Bono, V., Giacobbe, D.R., Bloodstream infections in internal medicine. Virulence 7 (2016), 353–365.
33. Pulcini, C., Botelho-Nevers, E., Dyar, O.J., Harbarth, S., The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect 20 (2014), 963–972.
34. Raineri, E., Pan, A., Mondello, P., Acquarolo, A., Candiani, A., Crema, L., Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 36 (2008), 283–290.
35. Rimawi, R.H., Mazer, M.A., Siraj, D.S., Gooch, M., Cook, P.P., Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 41 (2013), 2099–2107.
36. Lo, E., Rezai, K., Evans, A.T., Madariaga, M.G., Phillips, M., Brobbey, W., et al. Why don't they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis 38 (2004), 1212–1218.